DataInsightsOur ThinkingWhitepaper Protected: Disease landscapes: Meaningful scientific and strategic assessments for drug discovery and development There is no excerpt because this is a protected post.Nagendran PMarch 23, 2023
DataInsightsOur ThinkingWhitepaper Selecting and preparing data for AI/ML predictive modeling Find out the impact of data selection on the predictive accuracy of AI/ML models and…Nagendran PFebruary 28, 2023
Our ThinkingWhitepaper Optimizing scRNA-seq data analysis with effective pipeline development Single-cell RNA sequencing (scRNA-seq) allows genetic makeup to be studied at the level of single…Nagendran PJanuary 16, 2023
DataFeaturedInsightsR&D TechnologyWhitepaper Accelerating discovery and creating value Pharmas and biotechs are united by a common goal: discovery. Whether seeking new treatments, improved…Ben.frew@excelra.comOctober 20, 2022
DataWhitepaper Training machine learning algorithms on different data scales Poor drug solubility is one of the main obstacles in drug discovery and development and…Ben.frew@excelra.comOctober 20, 2022
Drug RepurposingFeaturedInsightsOur ThinkingWhitepaper Accelerated drug repurposing using advanced analytics Expertly curated data and advanced analytics have had a huge impact on drug repurposing –…Ben.frew@excelra.comOctober 20, 2022
Clinical Data ServicesDataOur ThinkingWhitepaper Optimizing preclinical toxicology data analysis with comprehensive, digitized reports To understand a drug's effect on the body, investigations take place to understand the pharmacokinetic…Ben.frew@excelra.comOctober 18, 2022